The demand for medically supervised weight loss using GLP-1 receptor agonists such as Ozempic, Wegovy, and Mounjaro has increased dramatically in recent months
One clinical trial found that participants regained about two-thirds of their previously lost weight within one year of stopping subcutaneous semaglutide.[10] Maintaining a relationship with a healthcare provider may help support long-term success by offering guidance, monitoring progress, and helping you build sustainable habits
Non-FDA approved compounded drugs claiming to contain semaglutide with high levels of known impurities and unknown impurities pose significant risks to patients and may lead to serious and life-threatening reactions, said Doug Langa, executive vice president of North America operations at Novo Nordisk
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 15, 155163
Which means the honest answer to "how much will I lose" is a range, not a number, and averages hide enormous spread
If authorized, your protocol is prepared by a partner compounding pharmacy and delivered direct to your door.
